Search research articles
Contact Us
Filters
Showing results (51-60 of 188) with videos related to
Page
of 19
Sort By:
Oncology Research
|
January 1, 1992
Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells
J Huang, J C Byrd, W H Yoon, et al.
The Journal of Biological Chemistry
|
November 15, 1989
Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells
S F Kuan, J C Byrd, C Basbaum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1989
Comparison of metabolically labeled mucins of LS174T human colon cancer cells in tissue culture and xenograft
B Siddiqui, J C Byrd, F J Fearney, et al.
Cancer
|
September 15, 1992
Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines
R Dahiya, S H Itzkowitz, J C Byrd, et al.
Cancer Research
|
August 15, 1989
ABH blood group antigen expression, synthesis, and degradation in human colonic adenocarcinoma cell lines
R Dahiya, S H Itzkowitz, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review
J C Byrd, W J Edenfield, D J Shields, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 17, 1998
An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor
G R Devi, J C Byrd, D H Slentz, et al.
Vox Sanguinis
|
March 21, 1998
Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma
D J Vick, J C Byrd, C L Beal, et al.
The American Review of Respiratory Disease
|
September 11, 1991
The structure of human intestinal apomucins
Y S Kim, J R Gum, J C Byrd, et al.
British Journal of Haematology
|
December 3, 1999
Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
J T Daniels, B J Davis, L Houde-McGrail, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 188) with videos related to
Sort By:
Page
of 19
Oncology Research
|
January 1, 1992
Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells
J Huang, J C Byrd, W H Yoon, et al.
The Journal of Biological Chemistry
|
November 15, 1989
Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells
S F Kuan, J C Byrd, C Basbaum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1989
Comparison of metabolically labeled mucins of LS174T human colon cancer cells in tissue culture and xenograft
B Siddiqui, J C Byrd, F J Fearney, et al.
Cancer
|
September 15, 1992
Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines
R Dahiya, S H Itzkowitz, J C Byrd, et al.
Cancer Research
|
August 15, 1989
ABH blood group antigen expression, synthesis, and degradation in human colonic adenocarcinoma cell lines
R Dahiya, S H Itzkowitz, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review
J C Byrd, W J Edenfield, D J Shields, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 17, 1998
An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor
G R Devi, J C Byrd, D H Slentz, et al.
Vox Sanguinis
|
March 21, 1998
Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma
D J Vick, J C Byrd, C L Beal, et al.
The American Review of Respiratory Disease
|
September 11, 1991
The structure of human intestinal apomucins
Y S Kim, J R Gum, J C Byrd, et al.
British Journal of Haematology
|
December 3, 1999
Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
J T Daniels, B J Davis, L Houde-McGrail, et al.
Page
of 19